DULUTH, Ga., Feb. 5, 2026 — Boehringer Ingelheim Animal Health USA Inc. announced that the U.S. Food and Drug Administration (FDA) has granted an Emergency Use Authorization (EUA) for IVOMEC® (ivermectin) 1% Injection to prevent infestations caused by New World screwworm (NWS) in cattle. The authorization marks the first EUA issued for an over-the-counter veterinary product for screwworm prevention, providing livestock producers and veterinarians with a critical intervention tool amid rising surveillance concerns following confirmed detections in northern Mexico.
Science Significance
The authorization reinforces the scientific importance of macrocyclic lactone antiparasitics in controlling myiasis-causing parasites. Ivermectin, the active ingredient in IVOMEC, disrupts neuromuscular transmission in parasitic larvae, leading to paralysis and death of the organism. In the case of Cochliomyia hominivorax, larvae infest open wounds and feed on living tissue, causing severe tissue destruction, secondary infections, and potential mortality. Administering ivermectin at high-risk intervention points — including within 24 hours of birth, at castration, or upon wound detection — enables early systemic protection before larval establishment. The EUA underscores ivermectin’s continued relevance as a scientifically validated parasiticide in large-animal health management and biosecurity preparedness.
Regulatory Significance
From a regulatory standpoint, the decision is highly significant. The FDA determined that no adequate, approved, and available alternatives exist for preventing NWS infestations at critical intervention stages, justifying emergency authorization under the Federal Food, Drug, and Cosmetic Act. The EUA permits temporary use of IVOMEC 1% Injection specifically for screwworm prevention under defined conditions, including usage restrictions in dairy cattle producing milk for human consumption and veal calves. Emergency authorizations are issued only when scientific evidence supports probable effectiveness and when urgent animal health threats require rapid access to countermeasures. This action reflects regulatory agility in responding to transboundary livestock disease risks.
Business Significance
Advertisement
Commercially, the EUA strengthens Boehringer Ingelheim’s leadership position in the global animal health parasiticide market. Emergency access authorization expands product utilization scenarios while reinforcing trust among veterinarians, ranchers, and government agencies. It also enhances the company’s portfolio visibility within livestock biosecurity frameworks, particularly in North America where screwworm eradication programs have historically required coordinated pharmaceutical and governmental responses. The authorization may drive increased demand for preventive parasiticides, distribution partnerships, and herd-health management programs aligned with outbreak preparedness planning.
Patients’ Significance
While the immediate beneficiaries are cattle, the downstream impact extends to food systems and public health. Preventing screwworm infestations protects animal welfare by reducing tissue trauma, infection risk, and mortality. Healthier cattle translate into improved productivity, reduced veterinary intervention costs, and more stable meat and dairy supply chains. By enabling early prevention at vulnerable life stages, the EUA supports humane livestock management and minimizes economic losses for producers. Safeguarding herd health also protects rural livelihoods and agricultural sustainability.
Policy Significance
At a policy level, the authorization reflects coordinated preparedness efforts among federal animal health authorities. Although NWS is not currently established in the United States, recent detections in Mexico have heightened surveillance and contingency planning. Emergency access to preventive therapeutics forms a core pillar of cross-border livestock disease defense strategies. The decision demonstrates how regulatory agencies can proactively authorize veterinary countermeasures to protect national food security, agricultural economies, and trade stability. It also highlights the integration of pharmaceutical innovation within government-led eradication and containment programs.
The FDA’s Emergency Use Authorization for IVOMEC® (ivermectin) 1% Injection marks a pivotal step in strengthening livestock biosecurity against the threat of New World screwworm. By enabling rapid preventive deployment, the authorization supports animal welfare, agricultural resilience, and food supply protection. As surveillance efforts continue across North America, access to scientifically validated parasiticides will remain central to safeguarding cattle populations and mitigating transboundary infestation risks.
Source: Boehringer Ingelheim Animal Health USA Inc. press release
